SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS |
The
following table summarizes stock-based compensation recognized for fiscal years 2022 and 2021.
SCHEDULE OF SHARE-BASED COMPENSATION, ALLOCATION OF RECOGNIZED PERIOD COSTS
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
2022 |
|
|
2021 |
|
Employee Stock Options |
|
$ |
313,000 |
|
|
$ |
178,000 |
|
Director Stock Options |
|
|
95,000 |
|
|
|
72,000 |
|
Total |
|
$ |
408,000 |
|
|
$ |
250,000 |
|
|
SCHEDULE OF STOCK OPTIONS ROLL FORWARD |
The
summary of the Company’s total plans as of December 31, 2022 and 2021, and changes during the period then ended are presented as
follows:
SCHEDULE OF STOCK OPTIONS ROLL FORWARD
|
|
Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic Value (2) |
|
Options outstanding January 1, 2022 |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
|
|
|
|
- |
|
Granted |
|
|
94,000 |
|
|
$ |
5.20 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(52,400 |
) |
|
$ |
4.04 |
|
|
|
|
|
|
$ |
97,856 |
|
Forfeited/expired |
|
|
(42,600 |
) |
|
$ |
4.08 |
|
|
|
|
|
|
|
|
|
Options outstanding end of period (1) |
|
|
1,018,400 |
|
|
$ |
5.02 |
|
|
|
3.8 |
|
|
$ |
44,262 |
|
Options exercisable at December 31, 2022(1) |
|
|
530,900 |
|
|
$ |
4.27 |
|
|
|
2.4 |
|
|
$ |
30,962 |
|
|
|
Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic Value (2) |
|
Options outstanding January 1, 2021 |
|
|
658,400 |
|
|
$ |
3.87 |
|
|
|
|
|
|
|
- |
|
Granted |
|
|
381,000 |
|
|
$ |
6.82 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(500 |
) |
|
$ |
3.15 |
|
|
|
|
|
|
$ |
2,175 |
|
Forfeited/expired |
|
|
(19,500 |
) |
|
$ |
6.75 |
|
|
|
|
|
|
|
|
|
Options outstanding end of period (1) |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
4.0 |
|
|
$ |
1,669,687 |
|
Options exercisable at December 31, 2021(1) |
|
|
438,400 |
|
|
$ |
3.95 |
|
|
|
2.7 |
|
|
$ |
1,064,432 |
|
(1) |
Options
with exercise prices ranging from $2.79 to $7.50 |
(2) |
The
intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price |
|
SCHEDULE OF NON VESTED OPTIONS |
The
summary of the Company’s nonvested options as of December 31, 2022 and changes during the period then ended are presented as follows:
SCHEDULE OF NON VESTED OPTIONS
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Grant-Date |
|
|
|
Shares |
|
|
Fair Value |
|
Non-vested options January 1, 2022 |
|
|
581,000 |
|
|
$ |
3.13 |
|
Granted |
|
|
94,000 |
|
|
|
3.39 |
|
Vested |
|
|
(154,500 |
) |
|
|
2.67 |
|
Forfeited |
|
|
(33,000 |
) |
|
|
3.08 |
|
Non-vested options at December 31, 2022 |
|
|
487,500 |
|
|
$ |
3.32 |
|
|